COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) |
|||
(4 intermediate revisions by one other user not shown) | |||
Line 8: | Line 8: | ||
=== {{AE}} === | === {{AE}} === | ||
* The name of the leaders are written in '''bold''': | |||
{{Multicol}} | {{Multicol}} | ||
'''First Draft of the page''' | '''First Draft of the page''' | ||
*'''[[User:Syed Hassan Abbas Kazmi|Syed Hassan Abbas Kazmi, M.D.]]''' | *'''[[User:Syed Hassan Abbas Kazmi|Syed Hassan Abbas Kazmi, M.D.]]''' | ||
Line 29: | Line 29: | ||
*[[user:Dr.Nuha|Nuha AL-Howthi, MD]] | *[[user:Dr.Nuha|Nuha AL-Howthi, MD]] | ||
*[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]] | *[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]] | ||
'''Endocrinology and COVID-19''' | |||
*'''[[User:Tayyaba Ali|Tayyaba Ali, M.D.]]''' | |||
* [[User:Anahita|Anahita Deilamsalehi, M.D.]] | |||
{{ColBreak}} | {{ColBreak}} | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
Line 86: | Line 89: | ||
*[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | *[[User:Rina Ghorpade|Rina Ghorpade, M.B.B.S.]] | ||
*[[User:Rija Gul|Rija Gul, M.B.B.S]] | *[[User:Rija Gul|Rija Gul, M.B.B.S]] | ||
'''Infectious Diseases and COVID-19''' | |||
'''Infectious | |||
* [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | * [[User:Zaida Obeidat|Zaida Obeidat, M.D.]] | ||
* [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | * [[User:Syed rizvi|Syed Rizvi, M.B.B.S.]] | ||
'''[[COVID-19 Medical Therapy]] | |||
'''[[COVID-19 | |||
* [[User:Sara Zand|Sara Zand, M.D.]] | * [[User:Sara Zand|Sara Zand, M.D.]] | ||
'''[[COVID-19 | '''[[COVID-19 Other Diagnostic Studies]] | ||
* [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] | * [[User:Mandana Safakhah|Mandana Safakhah, M.D.]] | ||
'''[[COVID-19 Vaccines]]''' | |||
* [[User:Jose Loyola|José Eduardo Riceto Loyola Junior, M.D.]] |
Latest revision as of 01:27, 24 August 2021
COVID-19 Project |
---|
Introduction |
Team |
Meetings' Summary |
Topics |
Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold: